Therasolve closes a EUR 2.4M series A financing round

Date: 22/01/2015

21 January 2015, Diepenbeek, Belgium – TheraSolve NV announces that it has recently closed an “A” financing round accounting for a total investment of EUR 2.4 million. The new investors are Ark Angels Activator Fund (AAAF) and Business Angels of BAN Vlaanderen. Together they are contributing EUR 900,000 on top of the investment by existing shareholders Thuja Capital and LRM. TheraSolve will use the capital collected in this round to finalise the development of the MemoPatch®, conduct patient pilot studies and market this new reminder technology to improve medical therapy adherence.

In a seed funding round in 2011, which involved Thuja Capital and LRM, TheraSolve gathered enough funds to finance the initial development and validation of the MemoPatch®. The new capitalisation provides additional funding as well as strategic and commercial know-how from AAAF and the Business Angels to the young undertaking.

Press releases can be found here in English and Dutch,